Centessa Pharmaceuticals plc Balance Sheet
CNTA / Health Care|7 years of annual SEC 10-K data (FY2019-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 7 fiscal years. All figures from audited SEC 10-K filings.
Centessa Pharmaceuticals plc had $687M in total assets and $527M in shareholders' equity as of FY2025. Total debt was $110M against $61M in cash, resulting in $49M net debt.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61.3M | $383.2M | $128.0M | $393.6M | $595.1M | $7.2M | - |
| Current Assets | $367.9M | $536.4M | $315.1M | $437.7M | $628.8M | $11.2M | - |
| PP&E (Net) | $807.0K | $744.0K | $1.0M | $1.2M | $162.0K | $0 | - |
| Total Assets | $687.5M | $576.8M | $360.2M | $444.3M | $629.6M | $11.7M | - |
| Current Liabilities | $42.9M | $58.0M | $39.4M | $38.3M | $24.6M | $8.6M | - |
| Total Debt | $110.1M | $108.9M | $0 | $69.8M | $75.7M | $0 | - |
| Shareholders' Equity | $526.9M | $401.5M | $236.2M | $336.2M | $491.6M | -$4.7M | - |